🔎 Trials Near Me

Beranda › Hipertensi Okular › Texas

Uji klinis Hipertensi Okular di Texas

8 studi untuk Hipertensi Okular mencari peserta di lokasi di Texas.

Kota di Texas

Teks studi resmi (Bahasa Inggris)

iDose TR Administration in an Office-Based Surgery Setting

  • Glaukos Investigative Site, Austin
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07816692

A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension

  • Houston Eye Associates, Houston
  • R and R eye research, San Antonio
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07661329

Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

  • Glaukos Clinical Site, El Paso
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07075718

Clarifying the Optimal Application of SLT Therapy Trial

  • Ophthalmology Associates, Fort Worth
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT04967989

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)

  • R and R Eye Research, LLC, San Antonio
Menerima pesertaFase 3
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 20 Okt 2025 · NCT07218796

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)

  • Houston Eye Associates, Houston
Menerima pesertaFase 3
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 20 Okt 2025 · NCT07218783

Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

  • Wilford Hall Ambulatory Surgical Center, Lackland Air Force Base
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2023 · NCT05844384

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

  • Keystone Research, Austin
  • Houston Eye Associates, North Loop, Houston
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2022 · NCT05401357

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.